𝔖 Bobbio Scriptorium
✦   LIBER   ✦

921 IS THE ROADMAP MODEL COST-EFFECTIVE IN THE ERA OF TENOFOVIR IN THE TREATMENT OF CHRONIC HEPATITIS B VIRUS (HBV) INFECTION?

✍ Scribed by Y.Y.N. Lui; K.K.F. Tsoi; V.W.S. Wong; H.L.Y. Chan

Book ID
117377926
Publisher
Elsevier Science
Year
2009
Tongue
English
Weight
50 KB
Volume
50
Category
Article
ISSN
0168-8278

No coin nor oath required. For personal study only.

πŸ“œ SIMILAR VOLUMES

Advances in the treatment of chronic hep
Advances in the treatment of chronic hepatitis B virus infection
✍ Adriana R. Marques; Stephen E. Straus πŸ“‚ Article πŸ“… 1998 πŸ› John Wiley and Sons 🌐 English βš– 244 KB πŸ‘ 2 views

Recent advances in our understanding of the replicative mechanism of HBV, and the development of potent nucleoside analogues as clinically effective inhibitors of the HIV reverse transcriptase or herpesvirus polymerases has opened a new era in the treatment of chronic HBV infection. Single agent the